153 related articles for article (PubMed ID: 24370550)
1. Reduced FHIT expression is associated with tumor progression in sporadic colon adenocarcinoma.
Kapitanović S; Čačev T; Lončar B; Catela Ivković T; Križanac Š; Pavelić K
Exp Mol Pathol; 2014 Feb; 96(1):92-7. PubMed ID: 24370550
[TBL] [Abstract][Full Text] [Related]
2. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
3. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
[TBL] [Abstract][Full Text] [Related]
4. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
[TBL] [Abstract][Full Text] [Related]
5. FHIT gene in gastric cancer: association with tumour progression and prognosis.
Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
[TBL] [Abstract][Full Text] [Related]
6. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
7. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.
Kapitanović S; Cacev T; Berković M; Popović-Hadzija M; Radosević S; Seiwerth S; Spaventi S; Pavelić K; Spaventi R
J Clin Pathol; 2004 Dec; 57(12):1312-8. PubMed ID: 15563674
[TBL] [Abstract][Full Text] [Related]
8. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.
Ingvarsson S; Sigbjornsdottir BI; Huiping C; Jonasson JG; Agnarsson BA
Cancer Detect Prev; 2001; 25(3):292-8. PubMed ID: 11425271
[TBL] [Abstract][Full Text] [Related]
10. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
[TBL] [Abstract][Full Text] [Related]
12. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
[TBL] [Abstract][Full Text] [Related]
13. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S
Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066
[TBL] [Abstract][Full Text] [Related]
15. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
[TBL] [Abstract][Full Text] [Related]
16. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
[TBL] [Abstract][Full Text] [Related]
17. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in the fragile histidine triad (FHIT) locus and expression analysis of FHIT protein in patients with breast disorders.
Rabelo RA; Antunes LM; Etchebehere RM; Nomelini RS; Nascentes GA; Murta EF; Pedrosa AL
Clin Exp Obstet Gynecol; 2013; 40(1):89-94. PubMed ID: 23724516
[TBL] [Abstract][Full Text] [Related]
19. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
Hong FZ; Wang B; Li HM; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
[TBL] [Abstract][Full Text] [Related]
20. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]